Personal information

Other IDs

Scopus Author ID: 24479642600

Activities

Collapse all

Employment (7)

Vita-Salute San Raffaele University: Milan, IT

2023-03-01 to present | Citizen Science and EU project communication officer (Research Development Area)
Employment
Source: Self-asserted source
Maya Fedeli

Vita-Salute San Raffaele University: Milan, IT

2019-10-01 to present | Project leader
Employment
Source: Self-asserted source
Maya Fedeli

Ospedale San Raffaele: Milano, Lombardia, IT

2011-05-01 to 2019-09-30 | Postdoctoral fellow (Experimental Immunology unit)
Employment
Source: Self-asserted source
Maya Fedeli

Ospedale San Raffaele: Milano, Lombardia, IT

2007-09-01 to 2011-04-19 | PhD student (Experimental Immunology Unit)
Employment
Source: Self-asserted source
Maya Fedeli

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2005-08-01 to 2007-08-31 | Fellow (Translational Research Unit)
Employment
Source: Self-asserted source
Maya Fedeli

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2004-04-01 to 2005-07-20 | Master student (Translational Research Unit)
Employment
Source: Self-asserted source
Maya Fedeli

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2003-04-01 to 2003-07-21 | Bachelor student (Ematology and Bone Marrow Transplantation Unit)
Employment
Source: Self-asserted source
Maya Fedeli

Education and qualifications (4)

Vita-Salute San Raffaele University: Milan, IT

2022-01-01 to 2023-01-25 | Master in Communication of Science and Health
Education
Source: Self-asserted source
Maya Fedeli

Università Vita Salute San Raffaele: Milano, Lombardia, IT

2008-01-01 to 2011-04-19 | PhD in Molecular Medicine - Section of Basic and Applied Immunology
Education
Source: Self-asserted source
Maya Fedeli

Università degli Studi di Milano: Milano, Lombardia, IT

2004-09-01 to 2005-07-20 | MS in Medical Biotechnology and Molecular Medicine
Education
Source: Self-asserted source
Maya Fedeli

Università degli Studi di Milano: Milano, Lombardia, IT

2000-09-01 to 2003-07-21 | BS in Medical Biotechnology
Education
Source: Self-asserted source
Maya Fedeli

Funding (1)

Cancer-induced invariant Natural Killer T cell dysfunction: molecular definition of a novel tumor escape mechanism

Grant
Fondazione Cariplo (Milan, IT)
GRANT_NUMBER:

2018-0366

Source: Self-asserted source
Maya Fedeli

Works (16)

TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells

Science Immunology
2022-08-26 | Journal article
DOI: 10.1126/sciimmunol.abn6563
Contributors: Gloria Delfanti; Filippo Cortesi; Alessandra Perini; Gaia Antonini; Laura Azzimonti; Claudia de Lalla; Claudio Garavaglia; Mario L. Squadrito; Maya Fedeli; Michela Consonni et al.
Source: check_circle
Crossref

Purification and expansion of mouse invariant natural killer t cells for in vitro and in vivo studies

Journal of Visualized Experiments
2021 | Journal article
DOI: 10.3791/62214
EID:

2-s2.0-85101749424

Part of ISSN: 1940087X
Contributors: Delfanti, G.; Perini, A.; Zappa, E.; Fedeli, M.
Source: Self-asserted source
Maya Fedeli via Scopus - Elsevier

miR‐21 sustains CD28 signalling and low‐affinity T‐cell responses at the expense of self‐tolerance

Clinical & Translational Immunology
2021-01 | Journal article
DOI: 10.1002/cti2.1321
Part of ISSN: 2050-0068
Part of ISSN: 2050-0068
Source: Self-asserted source
Maya Fedeli
grade
Preferred source (of 2)‎

Mir106b-25 and Mir17-92 Are Crucially Involved in the Development of Experimental Neuroinflammation.

Frontiers in neurology
2020-08-21 | Journal article
DOI: 10.3389/fneur.2020.00912
PMID: 32973667
PMC: PMC7473303
Source: Self-asserted source
Maya Fedeli
grade
Preferred source (of 2)‎

Data on the effects of eIF6 downmodulation on the proportions of innate and adaptive immune system cell subpopulations and on thymocyte maturation.

Data in brief
2017-08-30 | Journal article
DOI: 10.1016/j.dib.2017.08.023
PMID: 28924581
PMC: PMC5591389
Source: Self-asserted source
Maya Fedeli
grade
Preferred source (of 2)‎

High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4+ T cells in both mice and humans.

Developmental and comparative immunology
2017-07-22 | Journal article
DOI: 10.1016/j.dci.2017.07.022
PMID: 28743432
Source: Self-asserted source
Maya Fedeli
grade
Preferred source (of 2)‎

miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling.

Proceedings of the National Academy of Sciences of the United States of America
2016-12 | Journal article
DOI: 10.1073/pnas.1612024114
PMID: 27930306
PMC: PMC5187732
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

MicroRNA-133b Regulation of Th-POK Expression and Dendritic Cell Signals Affect NKT17 Cell Differentiation in the Thymus.

Journal of immunology (Baltimore, Md. : 1950)
2016-10 | Journal article
DOI: 10.4049/jimmunol.1502238
PMID: 27605013
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures.

European journal of immunology
2016-03 | Journal article
DOI: 10.1002/eji.201545787
PMID: 26639063
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.

PloS one
2013 | Journal article
DOI: 10.1371/journal.pone.0075348
PMID: 24205408
PMC: PMC3805464
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.

Journal of immunology (Baltimore, Md. : 1950)
2012-04 | Journal article
DOI: 10.4049/jimmunol.1103501
PMID: 22379027
PMC: PMC3559029
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice.

Journal of autoimmunity
2012-02 | Journal article
DOI: 10.1016/j.jaut.2011.12.004
PMID: 22225602
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Dicer-dependent microRNA pathway controls invariant NKT cell development.

Journal of immunology (Baltimore, Md. : 1950)
2009-08 | Journal article
DOI: 10.4049/jimmunol.0901361
PMID: 19625646
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.

Breast cancer research and treatment
2008-09 | Journal article
DOI: 10.1007/s10549-007-9777-3
PMID: 17914668
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report.

Pancreas
2008-05 | Journal article
DOI: 10.1097/mpa.0b013e31816705bc
PMID: 18437074
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎

A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.

Leukemia
2006-05 | Journal article
DOI: 10.1038/sj.leu.2404179
PMID: 16525489
Source: Self-asserted source
Maya Fedeli via Europe PubMed Central
grade
Preferred source (of 2)‎
How many people are using ORCID?